Cancer, Chemotherapy, device study Cancer Malignant neoplasm, unspecified
Conditions
Interventions
Patients will be randomised in a 3:1 ratio to receive either a Hickman line (n=75) or a Port-a-cath (n=25).
Patients participating in the study will be asked to complete quality of li
a further questionnaire will be completed at the time of planned line removal.
Patients will be seen as per standard of care for their treatment. Complication forms will be completed
Sponsors
NHS Greater Glasgow and Clyde (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Oncology patients with solid tumours who are scheduled for access line insertion 2. Patients must be willing and clinically able to receive either a Hickman line or a Port-a-cath 3. Patient must provide informed consent 4. Age =18 years, male and female 5. Able to comply with study protocol
Exclusion criteria
Exclusion criteria: 1. Any evidence of any medical or psychiatric disorders that would be a contra indication to study participation 2. Life expectancy < 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cost effectiveness of Ports | — |
Secondary
| Measure | Time frame |
|---|---|
| Complication data including line infection (with and without antibiotics), tract infection, (with/without antibiotics), occlusion, migration, loss of line, central vein thrombosis, exit site haematoma, and skin breakdown will be recorded by clinical staff, on complication forms in case notes, as events occur and data collected by the clinical trial coordinator. Reinterventions including line replacement, thrombolysis, stripping and manipulations will be recorded by clinical staff, on complication forms in case notes, as events occur and data collected by the clinical trial coordinator. | — |
Countries
United Kingdom
Outcome results
None listed